KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Gains from Investment Securities: 2009-2025

Historic Gains from Investment Securities for Tenet Healthcare (THC) over the last 17 years, with Q3 2025 value amounting to $87.0 million.

  • Tenet Healthcare's Gains from Investment Securities rose 2794.12% to $87.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $336.0 million, marking a year-over-year increase of 566.04%. This contributed to the annual value of $1.3 billion for FY2024, which is 42304.53% up from last year.
  • As of Q3 2025, Tenet Healthcare's Gains from Investment Securities stood at $87.0 million, which was up 2794.12% from $235.0 million recorded in Q2 2025.
  • In the past 5 years, Tenet Healthcare's Gains from Investment Securities registered a high of $963.0 million during Q4 2024, and its lowest value of -$28.0 million during Q1 2021.
  • In the last 5 years, Tenet Healthcare's Gains from Investment Securities had a median value of $31.0 million in 2023 and averaged $110.3 million.
  • Per our database at Business Quant, Tenet Healthcare's Gains from Investment Securities tumbled by 11052.63% in 2021 and then skyrocketed by 300645.16% in 2024.
  • Tenet Healthcare's Gains from Investment Securities (Quarter) stood at $146.0 million in 2021, then crashed by 91.1% to $13.0 million in 2022, then soared by 138.46% to $31.0 million in 2023, then surged by 3006.45% to $963.0 million in 2024, then plummeted by 90.97% to $87.0 million in 2025.
  • Its Gains from Investment Securities stands at $87.0 million for Q3 2025, versus $235.0 million for Q2 2025 and $7.0 million for Q1 2025.